{"title":"企业家精神与区域发展:最新进展","authors":"L. Carvalho","doi":"10.2174/2213809906666190102111108","DOIUrl":null,"url":null,"abstract":"\n\nThe presence of subvisible particles (SVPs) in parenteral formulations of biologics\nis a major challenge in the development of therapeutic protein formulations. Distinction between\nproteinaceous and non-proteinaceous SVPs is vital in monitoring formulation stability.\n","PeriodicalId":192959,"journal":{"name":"Technology Transfer and Entrepreneurship","volume":"49 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Entrepreneurship and Regional Development: State of the Art\",\"authors\":\"L. Carvalho\",\"doi\":\"10.2174/2213809906666190102111108\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nThe presence of subvisible particles (SVPs) in parenteral formulations of biologics\\nis a major challenge in the development of therapeutic protein formulations. Distinction between\\nproteinaceous and non-proteinaceous SVPs is vital in monitoring formulation stability.\\n\",\"PeriodicalId\":192959,\"journal\":{\"name\":\"Technology Transfer and Entrepreneurship\",\"volume\":\"49 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Technology Transfer and Entrepreneurship\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/2213809906666190102111108\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Technology Transfer and Entrepreneurship","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2213809906666190102111108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Entrepreneurship and Regional Development: State of the Art
The presence of subvisible particles (SVPs) in parenteral formulations of biologics
is a major challenge in the development of therapeutic protein formulations. Distinction between
proteinaceous and non-proteinaceous SVPs is vital in monitoring formulation stability.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
